Hit-to-lead development of CaMKII-HDAC4 inhibitory compounds to treat heart failure
| Institution | Universitätsklinikum Heidelberg |
|---|---|
| Project leader | Johannes Backs |
| Site | Heidelberg/Mannheim |
| Project type | Translational Research Project |
| Funding | € 1.237.084,83 |
| Begin | 01.11.2019 |
| End | 31.12.2022 |
| Partnerprojekte |
Förderkennzeichen
81X2500184
Projektnummer
1104